Latest Leverage News

Core Lithium has unveiled an updated mine plan for its Grants deposit at the Finniss Lithium Project, increasing the Ore Reserve by 33% and cutting pre-production capital costs by up to $45 million.

Buxton Resources has identified and de-risked three promising copper-gold drill targets at its Lateron Project in Western Australia, with drilling planned for 2026 following heritage agreement finalisation.

Algorae Pharmaceuticals has launched AlgoraeOS Version 2, a major AI platform upgrade that surpasses leading models including those from Google DeepMind, promising to accelerate drug-combination discovery.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

X2M Connect has secured over half a million Australian dollars in new and repeat water digitisation contracts in South Korea, driving strong early revenue growth in FY26. These deals expand the company’s footprint across thousands of households and highlight growing government adoption of IoT solutions.

E79 Gold Mines has reported encouraging assay results from air-core drilling at its Laverton South project, revealing gold mineralisation beneath the regional paleochannel and the discovery of gold nuggets at Pinjin. These findings bolster the company’s exploration potential ahead of planned deeper drilling and a key acquisition.

Integral Diagnostics has appointed Jason Martinez as its new CEO, set to lead the company’s growth and innovation efforts starting in 2026. Martinez brings over two decades of diagnostic imaging leadership experience, promising a strategic focus on expansion and operational excellence.

Iress launches a comprehensive FY26 business efficiency program targeting a 25% cash EBITDA margin, while narrowing its FY25 guidance and welcoming a new CEO.

Dyno Nobel Limited reported a robust 23% increase in EBIT for FY25, driven by strong explosives performance and transformation initiatives, while progressing its fertilisers separation and setting ambitious sustainability targets.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Count Limited reported robust FY2025 growth with funds under management surpassing $5.1 billion and increased dividends, while advancing its acquisition strategy and embracing AI-driven efficiencies.